0001209191-17-046031.txt : 20170721 0001209191-17-046031.hdr.sgml : 20170721 20170721201039 ACCESSION NUMBER: 0001209191-17-046031 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170719 FILED AS OF DATE: 20170721 DATE AS OF CHANGE: 20170721 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Silva Paul M CENTRAL INDEX KEY: 0001446372 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 17977418 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-07-19 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001446372 Silva Paul M C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 SVP & Corp Controller Common Stock 2017-07-19 4 M 0 6445 77.31 A 26516 D Common Stock 2017-07-19 4 M 0 4500 48.74 A 31016 D Common Stock 2017-07-19 4 M 0 8438 45.11 A 39454 D Common Stock 2017-07-19 4 M 0 3437 83.36 A 42891 D Common Stock 2017-07-19 4 M 0 3437 96.87 A 46328 D Common Stock 2017-07-19 4 M 0 3867 109.14 A 50195 D Common Stock 2017-07-19 4 M 0 6445 91.05 A 56640 D Common Stock 2017-07-19 4 M 0 3437 90.29 A 60077 D Common Stock 2017-07-19 4 S 0 40006 161.00 D 20071 D Common Stock 2017-07-21 4 S 0 2937 161.91 D 17134 D Common Stock 2017-07-21 4 S 0 500 161.92 D 16634 D Common Stock 169 I 401k Stock Option (Right to Buy) 77.31 2017-07-19 4 M 0 6445 0.00 D 2024-02-04 Common Stock 6445 3867 D Stock Option (Right to Buy) 48.74 2017-07-19 4 M 0 4500 0.00 D 2022-07-24 Common Stock 4500 0 D Stock Option (Right to Buy) 45.11 2017-07-19 4 M 0 8438 0.00 D 2023-02-04 Common Stock 8438 0 D Stock Option (Right to Buy) 83.36 2017-07-19 4 M 0 3437 0.00 D 2023-07-29 Common Stock 3437 860 D Stock Option (Right to Buy) 96.87 2017-07-19 4 M 0 3437 0.00 D 2024-07-14 Common Stock 3437 10313 D Stock Option (Right to Buy) 109.14 2017-07-19 4 M 0 3867 0.00 D 2025-02-02 Common Stock 3867 16758 D Stock Option (Right to Buy) 91.05 2017-07-19 4 M 0 6445 0.00 D 2026-02-01 Common Stock 6445 14180 D Stock Option (Right to Buy) 90.29 2017-07-19 4 M 0 3437 0.00 D 2026-07-11 Common Stock 3437 10313 D Transaction made pursuant to Mr. Silva's company-approved trading plan under Rule 10b5-1. The option vests in 16 quarterly installments from 2/5/2014. Fully vested. The option vests in 16 quarterly installments from 7/30/2013. The option vests in 16 quarterly installments from 7/15/2014. The option vests in 16 quarterly installments from 2/3/2015. The option vests in 16 quarterly installments from 2/2/2016. The option vests in 16 quarterly installments from 7/12/2016. /s/ Omar White, Attorney-in-Fact 2017-07-21